Sansum Diabetes Research Institute Announces Key Promotions
Strategic Promotions Drive Innovation and Patient Care in Diabetes Research
Sansum Diabetes Research Institute (SDRI) is pleased to announce the promotion of four esteemed employees to pivotal leadership roles. These promotions are a testament to their expertise, dedication, and significant contributions to SDRI’s mission of advancing diabetes research and improving patient care.
Kristin Castorino, DO, BC-ADM, has been promoted to Vice President, Clinical Research and Senior Research Physician. Dr. Castorino’s deep clinical experience and research acumen will be invaluable as she continues to lead our efforts to develop innovative treatments and interventions for those living with diabetes. Her leadership encompasses oversight of landmark studies and collaborations aimed at improving treatment outcomes and advancing diabetes care. Dr. Castorino has authored numerous papers, presented at national and international conferences, and is a sought-after collaborator in the field of maternal/fetal health. As a research physician who believes in elevating the health of people who live and work in our community, she also spends half-day a week working to provide care to vulnerable, at-risk patients.
Kara Hornbuckle, MS, has been promoted to Vice President, Development and Public Affairs. For seven years, Kara has been an integral part of building and repositioning SDRI. Her strategic role in the highly successful $20 million campaign, Innovative Research, Inspiring Hope, combined with her leadership across the organization in elevating SDRI’s development, marketing, educational, and engagement activities, position her well for an even more dynamic external role. Her focus will be overseeing development, marketing and communication strategies, educational programming, and managing SDRI’s public outreach initiatives.
Kara Hornbuckle, MS, has been promoted to Vice President, Development and Public Affairs. For seven years, Kara has been an integral part of building and repositioning SDRI. Her strategic role in the highly successful $20 million campaign, Innovative Research, Inspiring Hope, combined with her leadership across the organization in elevating SDRI’s development, marketing, educational, and engagement activities, position her well for an even more dynamic external role. Her focus will be overseeing development, marketing and communication strategies, educational programming, and managing SDRI’s public outreach initiatives.
Kristen Nelson, MSN, FNP, has been promoted to Director, Clinical Research Operations, a newly created role at SDRI. Kristen, a veteran nurse practitioner, has served as a senior member of the research team on countless studies. In her tenure, she has served as a teacher, trainer and mentor for the research assistants, research coordinators, nurses, and other nurse practitioners who implement the clinical trials that aim to change health span and health outcomes for people living with diabetes. Her new position will oversee the operational aspects of clinical research, including trial management, regulatory compliance, and patient engagement/patient safety.
Christian Farfan has been promoted to Director, Clinical Research Business Development. Over the last seven years, Christian learned and then managed a team that designed and delivered every facet of a clinical trial, from contract negotiation to patient recruitment to FDA review. His ability to see the big picture while managing a myriad of details, meant that under his leadership, our team delivered results for our partners. He has demonstrated exceptional skill in forging strategic partnerships and expanding SDRI’s research portfolio. In this newly created role, Christian will focus on developing business strategies, securing research funding, and fostering collaborations with industry and academic partners.
Christian Farfan has been promoted to Director, Clinical Research Business Development. Over the last seven years, Christian learned and then managed a team that designed and delivered every facet of a clinical trial, from contract negotiation to patient recruitment to FDA review. His ability to see the big picture while managing a myriad of details, meant that under his leadership, our team delivered results for our partners. He has demonstrated exceptional skill in forging strategic partnerships and expanding SDRI’s research portfolio. In this newly created role, Christian will focus on developing business strategies, securing research funding, and fostering collaborations with industry and academic partners.
“We are thrilled to recognize the accomplishments and achievements of Kristin, Kara, Kristen and Christian with these well-deserved promotions,” said Elizabeth Thompson, SDRI’s CEO. “These roles, and the public recognition of their importance, underscore our commitment to advancing diabetes research, education, and clinical care. Each of these talented individuals brings unique strengths and insights that will be crucial as we navigate the future and strive to make meaningful advancements in diabetes research.”
SDRI is dedicated to improving the lives of people impacted by diabetes through innovative research, education, and clinical care. These promotions reflect SDRI’s commitment to fostering talent and leadership within its team to drive forward its vision of reducing the burden of living with diabetes.